Does NALMEFENE Cause Leukocytosis? 6 Reports in FDA Database
Drink Less in 7 Days — Without Willpower
Clinically proven audio program. Just 25 min/day. Already helped 108,000+ people.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Leukocytosis have been filed in association with NALMEFENE (Zurnai). This represents 3.1% of all adverse event reports for NALMEFENE.
6
Reports of Leukocytosis with NALMEFENE
3.1%
of all NALMEFENE reports
6
Deaths
3
Hospitalizations
How Dangerous Is Leukocytosis From NALMEFENE?
Of the 6 reports, 6 (100.0%) resulted in death, 3 (50.0%) required hospitalization.
Is Leukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NALMEFENE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does NALMEFENE Cause?
Drug ineffective (66)
Coma (47)
Toxicity to various agents (43)
Hypotension (30)
Respiratory depression (25)
Depressed level of consciousness (19)
Hepatotoxicity (18)
Acute kidney injury (15)
Drug withdrawal syndrome (15)
Metabolic acidosis (14)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which NALMEFENE Alternatives Have Lower Leukocytosis Risk?
NALMEFENE vs NALOXEGOL OXALATE
NALMEFENE vs NALOXONE
NALMEFENE vs NALOXONE\OXYCODONE
NALMEFENE vs NALOXONE\TILIDINE
NALMEFENE vs NALTREXONE